These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38987827)

  • 1. Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer's disease pathology in the population?
    Pradeep A; Raghavan S; Przybelski SA; Preboske GM; Schwarz CG; Lowe VJ; Knopman DS; Petersen RC; Jack CR; Graff-Radford J; Cogswell PM; Vemuri P
    Alzheimers Res Ther; 2024 Jul; 16(1):157. PubMed ID: 38987827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer's disease pathology in the population?
    Pradeep A; Raghavan S; Przybelski SA; Preboske G; Schwarz CG; Lowe VJ; Knopman DS; Petersen RC; Jack CR; Graff-Radford J; Cogswell PM; Vemuri P
    Res Sq; 2024 Mar; ():. PubMed ID: 38558965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter hyperintensities: relationship to amyloid and tau burden.
    Graff-Radford J; Arenaza-Urquijo EM; Knopman DS; Schwarz CG; Brown RD; Rabinstein AA; Gunter JL; Senjem ML; Przybelski SA; Lesnick T; Ward C; Mielke MM; Lowe VJ; Petersen RC; Kremers WK; Kantarci K; Jack CR; Vemuri P
    Brain; 2019 Aug; 142(8):2483-2491. PubMed ID: 31199475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Data-Driven White Matter Hyperintensity Spatial Signatures With Distinct Cerebral Small Vessel Disease Etiologies.
    Phuah CL; Chen Y; Strain JF; Yechoor N; Laurido-Soto OJ; Ances BM; Lee JM;
    Neurology; 2022 Dec; 99(23):e2535-e2547. PubMed ID: 36123127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter hyperintensity patterns: associations with comorbidities, amyloid, and cognition.
    Bachmann D; von Rickenbach B; Buchmann A; Hüllner M; Zuber I; Studer S; Saake A; Rauen K; Gruber E; Nitsch RM; Hock C; Treyer V; Gietl A
    Alzheimers Res Ther; 2024 Apr; 16(1):67. PubMed ID: 38561806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer's disease.
    Zhang J; Chen H; Wang J; Huang Q; Xu X; Wang W; Xu W; Guan Y; Liu J; Wardlaw JM; Deng Y; Xie F; Li B
    Alzheimers Dement; 2024 Jun; 20(6):3931-3942. PubMed ID: 38648354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative MRI of cerebral white matter hyperintensities: A new approach towards understanding the underlying pathology.
    Iordanishvili E; Schall M; Loução R; Zimmermann M; Kotetishvili K; Shah NJ; Oros-Peusquens AM
    Neuroimage; 2019 Nov; 202():116077. PubMed ID: 31398433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White Matter Hyperintensity Volume and Amyloid-PET Synergistically Impact Memory Independent of Tau-PET in Older Adults Without Dementia.
    Edwards L; Thomas KR; Weigand AJ; Edmonds EC; Clark AL; Walker KS; Brenner EK; Nation DA; Maillard P; Bondi MW; Bangen KJ;
    J Alzheimers Dis; 2023; 94(2):695-707. PubMed ID: 37302031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
    Eloyan A; Thangarajah M; An N; Borowski BJ; Reddy AL; Aisen P; Dage JL; Foroud T; Ghetti B; Griffin P; Hammers D; Iaccarino L; Jack CR; Kirby K; Kramer J; Koeppe R; Kukull WA; La Joie R; Mundada NS; Murray ME; Nudelman K; Rumbaugh M; Soleimani-Meigooni DN; Toga A; Touroutoglou A; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu J; Mendez MF; Musiek E; Onyike CU; Rogalski E; Salloway S; Sha S; Turner RS; Wingo TS; Wolk DA; Womack K; Beckett L; Gao S; Carrillo MC; Rabinovici G; Apostolova LG; Dickerson B; Vemuri P;
    Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S89-S97. PubMed ID: 37491599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Fully Automated Visual Grading System for White Matter Hyperintensities of T2-Fluid Attenuated Inversion Recovery Magnetic Resonance Imaging.
    Rieu Z; Kim RE; Lee M; Kim HW; Kim D; Yong J; Kim J; Lee M; Lim H; Kim J
    J Integr Neurosci; 2023 May; 22(3):57. PubMed ID: 37258435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.
    Cha WJ; Yi D; Ahn H; Byun MS; Chang YY; Choi JM; Kim K; Choi H; Jung G; Kang KM; Sohn CH; Lee YS; Kim YK; Lee DY
    Alzheimers Res Ther; 2024 Mar; 16(1):50. PubMed ID: 38454444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between white matter hyperintensities and amyloid and tau deposition.
    Alban SL; Lynch KM; Ringman JM; Toga AW; Chui HC; Sepehrband F; Choupan J;
    Neuroimage Clin; 2023; 38():103383. PubMed ID: 36965457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral (deep) but not periventricular MRI white matter hyperintensities are increased in clinical vascular dementia compared to Alzheimer's disease.
    Smith CD; Johnson ES; Van Eldik LJ; Jicha GA; Schmitt FA; Nelson PT; Kryscio RJ; Murphy RR; Wellnitz CV
    Brain Behav; 2016 Mar; 6(3):e00438. PubMed ID: 26925303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition.
    Raghavan S; Przybelski SA; Reid RI; Lesnick TG; Ramanan VK; Botha H; Matchett BJ; Murray ME; Reichard RR; Knopman DS; Graff-Radford J; Jones DT; Lowe VJ; Mielke MM; Machulda MM; Petersen RC; Kantarci K; Whitwell JL; Josephs KA; Jack CR; Vemuri P
    Acta Neuropathol Commun; 2022 Feb; 10(1):16. PubMed ID: 35123591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns.
    Pålhaugen L; Sudre CH; Tecelao S; Nakling A; Almdahl IS; Kalheim LF; Cardoso MJ; Johnsen SH; Rongve A; Aarsland D; Bjørnerud A; Selnes P; Fladby T
    J Cereb Blood Flow Metab; 2021 May; 41(5):1162-1174. PubMed ID: 32955960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
    Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
    J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.
    Newton P; Tchounguen J; Pettigrew C; Lim C; Lin Z; Lu H; Moghekar A; Albert M; Soldan A;
    J Alzheimers Dis; 2023; 92(1):323-339. PubMed ID: 36744337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.
    Arfanakis K; Evia AM; Leurgans SE; Cardoso LFC; Kulkarni A; Alqam N; Lopes LF; Vieira D; Bennett DA; Schneider JA
    J Alzheimers Dis; 2020; 73(1):333-345. PubMed ID: 31771057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated White Matter Hyperintensity Segmentation Using Bayesian Model Selection: Assessment and Correlations with Cognitive Change.
    Fiford CM; Sudre CH; Pemberton H; Walsh P; Manning E; Malone IB; Nicholas J; Bouvy WH; Carmichael OT; Biessels GJ; Cardoso MJ; Barnes J;
    Neuroinformatics; 2020 Jun; 18(3):429-449. PubMed ID: 32062817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer's disease.
    Walsh P; Sudre CH; Fiford CM; Ryan NS; Lashley T; Frost C; Barnes J;
    Neurobiol Aging; 2020 Jul; 91():5-14. PubMed ID: 32305782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.